News
French pharma Ipsen (Euronext: IPN) today announced the following changes to its executive committee: Mari Scheiffele is appointed executive vice president (EVP) , chief product officer, Andreas ...
After 13 years at the helm of the UK’s BioIndustry Association, Steve Bates has tendered his resignation as chief executive ...
Patients in the UK will now be able to access advanced, personalized treatments prepared at the hospital or even in mobile ...
Swiss pharma Sandoz (SIX: SDZ) has spent less than a year charting its course as an independent company, but already it’s ...
French biotech ImCheck Therapeutics has announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to its lead program, ICT01, a humanized anti-butyrophilin 3A (BTN3A ...
Shares in Replimune Group, a US biotech developing novel oncolytic immunotherapies, went in freefall Tuesday, as the company ...
Neuraxpharm Group, a privately-held German specialty pharma focused on central nervous system (CNS) disorders, today announced the launch of a new affiliate, Neuraxpharm Australia, led by newly ...
US biotech iTeos Therapeutics yesterday announced that it has entered into a definitive merger agreement Concentra Biosciences, a vehicle controlled by hedge fund Tang Capital Partners, this year, ...
Ireland-based Alkermes has announced positive topline results from the randomized double-blind treatment period of the ...
Canadian biotech Eyam Health has entered a research alliance with Swiss-based nonprofit Medicines for Malaria Venture to ...
French pharma major Sanofi today announced it has entered into an agreement to acquire Vicebio, a privately held biotechnology company headquartered in London, UK.
Shares in Sarepta Therapeutics have slumped by more than a third since late last week amid new updates on its gene therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results